{{Rsnum
|rsid=2184658
|Gene=HLX
|Chromosome=1
|position=220879115
|Orientation=plus
|GMAF=0.1593
|Gene_s=HLX
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;G)
| geno3=(G;G)
| CEU | 58.1 | 41.9 | 0.0
| HCB | 84.4 | 15.6 | 0.0
| JPT | 75.0 | 22.7 | 2.3
| YRI | 50.0 | 40.3 | 9.7
| ASW | 0.0 | 0.0 | 0.0
| CHB | 84.4 | 15.6 | 0.0
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=22014209
|Title=Functional polymorphisms in TBX21 and HLX are associated with development and prognosis of Graves' disease
}}